DEXTRAN SULFATE AS AN INHIBITOR AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS

被引：0
|
作者：
CHANG, RS
TABBA, HD
HE, YS
SMITH, KM
机构：
[1] UNIV CALIF DAVIS, DEPT MED MICROBIOL & IMMUNOL, DAVIS, CA 95616 USA
[2] UNIV CALIF DAVIS, DEPT CHEM, DAVIS, CA 95616 USA
来源：
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 1988年 / 189卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：304 / 309
页数：6
相关论文
共 50 条
  • [31] CHEMOTHERAPY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    WILKS, D
    DALGLEISH, AG
    MOLECULAR ASPECTS OF MEDICINE, 1991, 12 (04) : 313 - 328
  • [32] EFFECT OF DEXTRAN SULFATE ON FUSION OF SENDAI VIRUS WITH HUMAN ERYTHROCYTE-GHOSTS
    OHKI, S
    ARNOLD, K
    SRINIVASAKUMAR, N
    FLANAGAN, TD
    BIOMEDICA BIOCHIMICA ACTA, 1991, 50 (02) : 199 - 206
  • [33] A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane x receptor
    Healan-Greenberg, Christine
    Waring, Jeffrey F.
    Kempf, Dale J.
    Blomme, Eric A. G.
    Tirona, Rommel G.
    Kim, Richard B.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (03) : 500 - 507
  • [34] Lecithinized superoxide dismutase: An inhibitor of human immunodeficiency virus replication
    Premanathan, M
    Nakashima, H
    Igarashi, R
    Mizushima, Y
    Yamada, K
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (04) : 283 - 290
  • [35] Trichoderma Rifai as human immunodeficiency virus inhibitor producer.
    Smirnova, IP
    Alexeev, SB
    Moshkoff, DA
    VOPROSY MEDITSINSKOI KHIMII, 2000, 46 (04): : 384 - 387
  • [36] Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor
    Lin, PF
    Samanta, H
    Bechtold, CM
    Deminie, CA
    Patick, AK
    Alam, M
    Riccardi, K
    Rose, RE
    White, RJ
    Colonno, RJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 133 - 138
  • [37] Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition
    Connell, Bridgette J.
    Lortat-Jacob, Hugues
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [38] Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein
    Este, JA
    Schols, D
    DeVreese, K
    VanLaethem, K
    Vandamme, AM
    Desmyter, J
    DeClercq, E
    MOLECULAR PHARMACOLOGY, 1997, 52 (01) : 98 - 104
  • [39] HUMAN MONOCLONAL-ANTIBODY AGAINST GLYCOPROTEINS OF HUMAN IMMUNODEFICIENCY VIRUS
    SUGANO, T
    MASUHO, Y
    MATSUMOTO, Y
    LAKE, D
    GSCHWIND, C
    PETERSEN, EA
    HERSH, EM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (03) : 1105 - 1112
  • [40] Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy
    Kravcik, S
    Victor, G
    Angel, JB
    Badley, AD
    Garber, GE
    Cameron, DW
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 702 - 703
12345